Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
56.90
-0.79 (-1.37%)
At close: Dec 5, 2025, 4:00 PM EST
56.96
+0.06 (0.11%)
After-hours: Dec 5, 2025, 7:35 PM EST
Nektar Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Nektar Therapeutics stock have an average target of 106.33, with a low estimate of 90 and a high estimate of 121. The average target predicts an increase of 86.87% from the current stock price of 56.90.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Nektar Therapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 7 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Initiates $102 | Strong Buy | Initiates | $102 | +79.26% | Nov 26, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $99 → $121 | Strong Buy | Maintains | $99 → $121 | +112.65% | Nov 26, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $85 → $105 | Strong Buy | Maintains | $85 → $105 | +84.53% | Sep 23, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +75.75% | Sep 19, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $60 → $85 | Strong Buy | Maintains | $60 → $85 | +49.38% | Jul 8, 2025 |
Financial Forecast
Revenue This Year
44.37M
from 98.43M
Decreased by -54.92%
Revenue Next Year
42.69M
from 44.37M
Decreased by -3.79%
EPS This Year
-10.61
from -8.68
EPS Next Year
-9.96
from -10.61
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 51.7M | 57.2M | ||||
| Avg | 44.4M | 42.7M | ||||
| Low | 39.2M | 23.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -47.5% | 28.8% | ||||
| Avg | -54.9% | -3.8% | ||||
| Low | -60.2% | -47.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -10.20 | -7.01 | |||
| Avg | -10.61 | -9.96 | |||
| Low | -11.36 | -11.88 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.